Red X iconGreen tick iconYellow tick icon
Clinical Professor
Department of Medicine (Christchurch)
Research summary
Liver disease


Dr Stedman's field of research is liver disease and pharmacology, focusing on hepatitis C and autoimmune liver diseases. Her published papers in hepatitis C epidemiology have influenced global understanding of chronic hepatitis C epidemiology including government and Ministry of Health understanding and approach to hepatitis C treatment strategies.


Stedman, C. (2023, May). Hepatitis C and liver disease: The journey to cure and eliminate. University of Otago, Christchurch, New Zealand. [Inaugural Professorial Lecture]. Other Research Output

Cheng, Q., Cunningham, E. B., Shih, S., Amin, J., Bruneau, J., Artenie, A. A., … Stedman, C., … on behalf of the SIMPLIFY and D3FEAT Study Groups. (2023). Patient reported outcomes during and following HCV direct-acting antiviral treatment among people who inject drugs. Value in Health. Advance online publication. doi: 10.1016/j.jval.2022.12.016 Journal - Research Article

Walter, T., Connor, S., Stedman, C., & Doogue, M. (2022). A case of acute necrotising pancreatitis following the second dose of Pfizer-BioNTech COVID-19 mRNA vaccine. British Journal of Clinical Pharmacology, 88, 1385-1386. doi: 10.1111/bcp.15039 Journal - Research Other

Lamba, M., Ngu, J. H., & Stedman, C. A. M. (2021). Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis. Clinical Gastroenterology & Hepatology, 19(3), 573-579.e1. doi: 10.1016/j.cgh.2020.05.061 Journal - Research Article

Cunningham, E. B., Hajarizadeh, B., Amin, J., Hellard, M., Bruneau, J., Felderhof, J. J., … Stedman, C., … on behalf of the SIMPLIFY and D3FEAT Study Groups. (2021). Reinfection following successful direct-acting antiviral therapy for hepatitis C infection among people who inject drugs. Clinical Infectious Diseases, 72(8), 1392-1400. doi: 10.1093/cid/ciaa253 Journal - Research Article

Back to top